Immulina 400mg Strip Of 10 Tablets
Description
Immulina 400mg tablet contains pidotimod as the main ingredient. It is used to treat respiratory tract infections. Pidotimod acts by modulating the activity of the immune system. This helps to treat
infections. This medicine is only available on a doctor's prescription and should be taken at a dose and for a duration prescribed by the doctor. Do not use this medicine during pregnancy and breastfeeding unless recommended by a doctor. In addition, do not use this medicine in children unless recommended by their doctor. Before taking this medicine, inform your doctor if you are allergic to any ingredients. Contact your doctor immediately if you notice any unusual side effects after taking this medicine.
Product Summary
Offer Price | ₹259.11 |
You Save | ₹77.39 (23% on MRP) |
Contains | Pidotimod(400.0 Mg) |
Uses | Respiratory infections |
Side effects | Diarrhoea |
Therapy | IMMUNOMODULATOR |
Uses
- Respiratory tract infections
Contraindications
- If you are allergic to any ingredients of Immulina tablet
Side effects
- Diarrhoea
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You are allergic to any ingredients of Immulina tablet
- You are consuming other medications or supplements
Mode of Action
How Does It Work?
Directions for Use
- The dose and duration of the medicine must be followed strictly as directed by the doctor
- Consume the tablets with water
- Do not crush, chew, or break the tablets
Storage and disposal
- Keep the medicine away from reach from children and pets
- Do not use the medicine after expiry date
- Do not throw medicines in wastewater or household waste
Dosage
Overdose
Missed a Dose
Content Details
Frequently Asked Questions (FAQs)
Q: Can I use Immulina tablet in my children?
Q: Does Immulina tablet cause weight gain?
Q: Does Immulina tablet affects fertility?
References
- Walavalkar KC, Joshi M, Kelkar M, Kulkarni S, Tuteja V, Scarci F. Efficacy and safety of pidotimod as adjuvant in the treatment of recurrent upper respiratory tract infections (URTI) in children. Trends Med. 2014;14:11-6.
- Ferrario B, Garuti S, Braido F, Canonica G. Pidotimod: the state of art. Clinical and Molecular Allergy. 2015;13(1).
- Mahashur A, Thomas P, Mehta P, Nivangune K, Muchhala S, Jain R. Pidotimod: In-depth review of current evidence. Lung India. 2019;36(5):422.
Did you find this medicine information helpful?
Please rate your experience
Other Products from this Brand
Blog Articles
Chronic Condition Articles
Top-Tests we cover:
Top-Selling Healthcare Products:
Top-Selling Medicines:
Top-Searched Medicines: